GTX Inc (NASDAQ:GTXI)

19.35
Delayed Data
As of Jun 15
 +0.01 / +0.05%
Today’s Change
4.01
Today|||52-Week Range
23.40
+52.24%
Year-to-Date

Today’s Trading

Previous close19.34
Today’s open19.38
Day’s range19.21 - 19.83
Volume74,610
Average volume (3 months)124,870
Market cap$380.9M
Data as of 4:00pm ET, 06/15/2018

Growth & Valuation

Earnings growth (last year)-43.44%
Earnings growth (this year)-1.43%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book9.81

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...+0.03+4.41%
GLMDGalmed Pharmaceutica...+0.34+2.12%
ZFGNZafgen Inc+0.06+0.86%
MEIPMEI Pharma Inc-0.11-2.53%
Data as of 4:00pm ET, 06/15/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$0.00
Annual profit (last year)-$30.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts